E, W., AD, D., U, J., M, X., W, M., S, S., & D, S. (2026). Brain interstitial fluid pharmacokinetics and therapeutic effect of a BBB penetrating amyloid beta antibody measured by microdialysis. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 23(4), e00949. https://doi.org/10.1016/j.neurot.2026.e00949
Chicago Style (17th ed.) CitationE, Wik, Dahlén AD, Julku U, Xiong M, Michno W, Syvänen S, and Sehlin D. "Brain Interstitial Fluid Pharmacokinetics and Therapeutic Effect of a BBB Penetrating Amyloid Beta Antibody Measured by Microdialysis." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics 23, no. 4 (2026): e00949. https://doi.org/10.1016/j.neurot.2026.e00949.
MLA (9th ed.) CitationE, Wik, et al. "Brain Interstitial Fluid Pharmacokinetics and Therapeutic Effect of a BBB Penetrating Amyloid Beta Antibody Measured by Microdialysis." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, vol. 23, no. 4, 2026, p. e00949, https://doi.org/10.1016/j.neurot.2026.e00949.